Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajdeep Das

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Nature Communications|August 30, 2019
Author Correction: Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanismsNima C Emami, Linda Kachuri, Travis J Meyers, et al.
Cancer Research|May 6, 2017
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate CancerSteve Paltoglou, Rajdeep Das, Scott L Townley, et al.
Nature Communications|July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancerRajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP InhibitorsJonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate CancerHui Li, Noah S Younger, Bhavna Malik, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Nature Communications|August 30, 2019
Author Correction: Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanismsNima C Emami, Linda Kachuri, Travis J Meyers, et al.
Cancer Research|May 6, 2017
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate CancerSteve Paltoglou, Rajdeep Das, Scott L Townley, et al.
Nature Communications|July 30, 2021
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancerRajdeep Das, Martin Sjöström, Raunak Shrestha, et al.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP InhibitorsJonathan Chou, Troy M Robinson, Emily A Egusa, et al.
Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate CancerHui Li, Noah S Younger, Bhavna Malik, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Pageof 8